Intrapleural use of tissue plasminogen activator and DNase in pleural infection

Intrapleural use of tissue plasminogen activator and DNase in pleural infection

Show other versions (1)

BACKGROUND: More than 30% of patients with pleural infection either die or require surgery. Drainage of infected fluid is key to successful treatment, but intrapleural fibrinolytic therapy did not improve outcomes in an earlier, large, randomized trial. METHODS: We conducted a blinded, 2-by-2 factor...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Rahman, N, Maskell, N, West, A, Teoh, R, Arnold, A, Mackinlay, C, Peckham, D, Davies, C, Ali, N, Kinnear, W, Bentley, A, Kahan, B, Wrightson, J, Davies, H, Hooper, C, Lee, Y, Hedley, E, Crosthwaite, N, Choo, L, Helm, E, Gleeson, F, Nunn, A, Davies, R
פורמט: Journal article
שפה:English
יצא לאור: 2011

פריטים דומים

פריטים דומים